TrialmAbs

Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allografts.

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.